Podcasts about Breast cancer screening

“That's what metastatic breast cancer looks like now—patients can live an extended period of time. And sometimes I think we forget to cheer for stable disease. I tell patients they can live with weeds in their garden; they just can't let the weeds take over their garden. And today we don't have a cure. We live in a rapidly changing time in oncology, and so there's just so much hope right now that we can offer patients,” ONS member Kristi Orbaugh, RN, MSN, RNP, AOCN®, nurse practitioner at Community Hospital North Cancer Center in Indianapolis, IN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about patient communication in the metastatic breast cancer setting. This podcast episode was developed by ONS through a sponsorship from Lilly. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes  This episode is not eligible for NCPD.  ONS Podcast™ episodes: Episode 354: Breast Cancer Survivorship Considerations for Nurses Episode 350: Breast Cancer Treatment Considerations for Nurses Episode 345: Breast Cancer Screening, Detection, and Disparities ONS Voice articles: Black Patients With Metastatic Breast Cancer Are Less Informed About Their Clinical Trial Options What Is HER2-Low Breast Cancer? ONS books: Guide to Breast Care for Oncology Nurses ONS course: Breast Cancer Bundle Oncology Nursing Forum article: Relations of Mindfulness and Illness Acceptance With Psychosocial Functioning in Patients With Metastatic Breast Cancer and Caregivers ONS Biomarker Database American Cancer Society breast cancer resources METAvivor National Cancer Institute resources: Breast cancer—Patient version To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “I think the most important and vital piece of having those conversations is making sure that we know—really know—that patient, because if we know them, that helps guide what they're needing right then, helps guide our verbiage, helps guide disciplines that we bring in.” TS 2:04 “What do they want to hear? I've been in practice a really, really long time, and I've had the entire spectrum. I've had patients say, ‘Tell me every single detail.' I mean, they want pictures. They want graphs. They want me to draw things. I've even had patients that want me to take markers and mark their body parts. … And then I've had patients that say, ‘I don't want to know anything. I trust my healthcare team. I'm going to proceed with treatment, but I really don't want to know anything.'” TS 3:40 “Remember to make things as simple as possible until we really know what the patient knows. We don't send our children to school and start them out in eighth grade; we send them to kindergarten for a reason. So we get basic information, and then we build on that. And I think we need to remember that when we're doing our patient education, whether it's regarding new chemotherapy or treatment plans or palliative care, we've got to remember to start simple. And maybe we build on that very quickly, or maybe it takes a bit more time. Number one—I actually think it helps with adherence because patients understand what we're asking of them and why we're asking that of them.” TS 12:00 “I think what's really kind of key to keep in mind is that patients are going to seek information. And so, we need to make sure that we're giving them really good, reliable, durable information because if we are not giving them good websites, if we're not giving them good written material, if we're not giving them good verbal information and education, they're going to contact ‘Dr. Google.' Dr. Google is good for a lot of things, but sometimes patients can go down a rabbit hole that's not appropriate or not accurate. That's not a good place for them to be.” TS 14:35 “If we find biomarkers that we call actionable, meaning that we find this mutation and we have a drug that blocks that mutation, that is what is going to guide and drive our treatment. Sometimes that can take a bit of time, right? And if we have a patient and they just find out they have metastatic disease, will they want treatment yesterday. And I understand that. … But frequently there is a very important period of waiting and allowing us to learn that enemy better by reviewing genomic testing, looking at that next-generation sequencing, looking at any positive biomarkers in breast cancer. They may have started out ER/PR positive. Are they still ER/PR positive?” TS 23:46 “I think when we're talking about goals of care, first of all, we need to make sure that the patient understands, when we're talking about metastatic disease today…, this is not a disease that we can cure, but hopefully it's a disease that we can manage for years to come. With that in mind, what's important to that patient? What is important to that patient in terms of life goals? What's important to that patient in terms of toxicities that they will allow and toxicities that they won't allow? TS 29:22 “If don't have a lot of medical knowledge, taking a pill seems less important than getting an IV. It seems like a bigger deal if I would miss getting my IV therapy. ‘Oh, whoops, I forgot to take a pill. Maybe it's not such a big, important piece of my treatment.' So education—when we set that patient down, helping them understand how this drug works, mechanism of action in a simple term, why it's important to take it as scheduled, why it's important to take it with food or without food, why it's important to take it consistently.” TS 34:41

The NHS in England has launched a new phase of the ‘Help Us, Help You' campaign to encourage blind and partially sighted women to attend their breast screening appointment when invited. Amelia spoke to RNIB Chair Of Trustees, Anna Tylor, about the importance of attending screening appointments. Learn more about breast cancer screenings by going to Breast screening (mammogram) - NHS You can request an accessible version of the breast cancer screening easy read guide by emailing england.contactus@nhs.net Image shows the RNIB Connect Radio logo. On a white background ‘RNIB' written in bold black capital letters and underline with a bold pink line. Underneath the line: ‘Connect Radio' is written in black in a smaller font. 

While mammograms are often pushed at age 40 as the gold standard for breast health screening, many women are questioning the risk-reward ratio and seeking safer, more holistic alternatives. Could thermography be a more proactive, less harmful approach to identifying early dysfunction in the body? This episode explores the topic of thermography as a non-invasive, radiation-free tool for wellness assessment.  In this episode, we are  joined by special guest Amanda Allen, owner of Austin Thermography, to break down the science, safety, and practical application of thermal imaging. We discuss how thermography differs from conventional screenings, what types of patterns it can detect—ranging from inflammation to hormonal imbalances—and how it may serve as an early warning system long before a disease manifests structurally. Whether you're looking to support breast health, monitor chronic conditions, or simply stay in tune with your body's signals, this episode will help you consider if thermography has a place in your wellness toolbox. More about Amanda Allen of Austin Thermography:  Amanda is trained and certified by the Professional Academy of Clinical Thermology as a Thermographic Technician. As the owner of Austin Thermography, she provides the highest quality thermographic imaging, using the latest, most advanced infrared camera available, so you can have a more complete picture of your health.  Amanda has 15 years of experience in patient care and takes great pride in putting her clients at ease throughout the screening process.   More information here:  Austin Thermography Breast Thermography International   Also in this episode:  Episode 313 Estrogen Metabolism and Breast Health Why Ali's opting out of mammogram Exposing the Mammogram Myth: A New Era of Breast Cancer Screening with Dr. Jenn Simmons Amanda's Story What is thermography? Lymph activation Episode 298 Moving Your Lymph The importance of early detection How to prep for thermography How EMF can interfere Episode 394 The Human Electrical Force Patient success stories Breastfeeding and pregnancy concerns   Sponsors for this episode:  This episode is sponsored by FOND Bone Broth, your sous chef in a jar. FOND's bone broths and tallows are produced in small batches with premium ingredients from verified regenerative ranches. Their ingredients are synergistically paired for maximum absorption, nutritional benefit, and flavor. Use code ALIMILLERRD to save at https://fondbonebroth.com/ALIMILLERRD. 

Subscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsBreast cancer screening, prevention, and treatment are evolving, and in this episode, integrative oncologist and former breast surgeon Dr. Jenn Simmons reveals why it's time to rethink the mammogram. With breast cancer rates rising globally, many women are undergoing aggressive treatments for conditions that may never become life-threatening. Dr. Simmons breaks down the truth about mammography risks, the limitations of early detection, and introduces safer, more effective screening methods grounded in functional medicine and metabolic health.This powerful conversation covers the real root causes of breast cancer, including chronic inflammation, environmental toxins, and metabolic dysfunction. Dr. Simmons shares her deeply personal story,  from leading a top surgical practice to becoming a patient herself — and how that experience transformed her approach to care. She also explains why prevention must go beyond imaging.You will learn how nutrition, lifestyle changes, hormone therapy, and advanced lab testing can play a transformative role in both preventing breast cancer and improving outcomes after diagnosis. This is a must-watch episode for anyone ready to move from fear to empowerment in their breast health journey.Thank you to our sponsorGet 15% off your first order with the code DRTAZ at oneskin.co/drtazConnect further to Hol+ at https://holplus.co/- Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+.About Jenn Simmons:Dr. Jenn Simmons is an Integrative Oncologist, Breast Surgeon, Author, Podcast Host, and the founder of PerfeQTion Imaging. Her journey into breast cancer care began with a personal tragedy. At the age of 16, Dr. Jenn's cousin, acclaimed singer-songwriter Linda Creed, died of metastatic breast cancer just weeks after Whitney Houston's recording of her iconic song, "The Greatest Love of All," topped the charts. This loss became a defining moment, inspiring Dr. Jenn to dedicate her life to transforming how we approach breast cancer treatment and prevention.Dr. Jenn became Philadelphia's first fellowship-trained breast surgeon and spent 17 years leading the field. However, her perspective changed significantly when she became a patient herself. Through this personal experience, Dr. Jenn saw how broken the conventional medical system can be. This led her to discover and embrace functional medicine, a revelation that sparked her journey towards a more holistic approach to breast cancer care.This personal journey led her to create Real Health MD in 2019, a practice dedicated to holistic healing for breast cancer. It integrates conventional wisdom with root cause medicine and the drivers of health: nutrition, lifestyle changes, detoxification, and stress management. Dr. Jenn's innovative approach doesn't stop there. As the founder of PerfeQTion Imaging, she is establishing safe imaging centers across the nation, armed with revolutionary technology that promises to redefine breast cancer screening. This technology is not only fast and safe but also comfortable, affordable, radiation-free, and boasts 40 times the resolution of MRI. It has received FDA clearance, signaling a new era in breast health and breast cancer screening.In addition to her clinical practice, Dr. Jenn hosts the "Keeping Abreast" podcast, where she shares her expertise and encourages women to take control of their breast health. Her book, "The Smart Woman's Guide to Breast Cancer," challenges conventional wisdom and promotes a holistic approach. It emphasizes the importance of nutrition, lifestyle choices, and addressing environmental toxins, providing practical steps for women seeking to navigate breast cancer treatment and regain control of their health.Beyond her professional endeavors, Dr. Jenn is a devoted wife, mother, stepmother, grandmother, and athlete. Her life's mission is deeply personal, rooted in her cousin's memory, and driven by a desire to make a lasting impact on all those who desire breast health. As she famously says, "Breast Health is Health!"Stay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Follow Dr. Jenn Simmons on Instagram:https://www.instagram.com/drjennsimmons/https://www.instagram.com/perfeqtionimaging/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)00:00 Introduction 02:50 Meet Dr. Jenn Simmons11:43 Discovering Functional Medicine14:36 The Flaws in Conventional Breast Cancer Screening25:01 The Mammogram Debate35:19 Self-Breast Examination: Know Your Lumps37:00 Introducing the ARIA Test43:30 The Role of Diet and Metabolic Health48:43 Alcohol and Breast Cancer Risk57:08 Hormone Replacement Therapy: Myths and Facts01:04:00 A Message of Hope and Empowerment01:06:42 Conclusion 

“You can give someone a survivorship care plan, but just giving them doesn't mean that it's going to happen. Maybe there's no information about family history. Or maybe there's information and there's quite a bit of family history, but there's nothing that says, ‘Oh, they were ever had genetic testing,' or ‘Oh, they were ever referred.' So the intent is so good because it's to really take that time out when they're through with active treatment and, you know, try to help give the patient some guidance as to what to expect down the line,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in Missouri, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about breast cancer survivorship.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to breast cancer survivorship.  Episode Notes   Complete this evaluation for free NCPD.   Previous ONS Podcast™ site-specific episodes: Episode 350: Breast Cancer Treatment Considerations for Nurses  Episode 348: Breast Cancer Diagnostic Considerations for Nurses  Episode 345: Breast Cancer Screening, Detection, and Disparities  ONS Voice articles: Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  Improve Management of Common Symptoms for Breast Cancer Survivors  Nursing Considerations for Breast Cancer Survivorship Care  Sexual Considerations for Patients With Cancer ONS books:  Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses  ONS course: Breast Cancer Bundle  ONS Learning Libraries:  Breast Cancer  Genomics and Precision Oncology  Nurse Navigation  Oral Anticancer Medication   Survivorship  ONS Guidelines™ and Symptom Interventions:  Anxiety  Cognitive Impairment  Depression  Fatigue  Clinical Journal of Oncology Nursing article: Survivorship Care: More Than Checking a Box  Clinical Journal of Oncology Nursing supplement: Survivorship Care  American Cancer Society:  Cancer Treatment and Survivorship Facts and Figures  Survivorship: During and After Treatment  Livestrong® Program at the YMCA  National Comprehensive Cancer Network  National Cancer Institute Breast Cancer—Patient Version    To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “I think the biggest thing is to really communicate is that people are living with breast cancer for a long, long periods of time, and a lot of that with really good quality overall.” TS 4:07   “As a general rule, they're going to be seen by the breast surgeon probably every four to six months for a while. After about five years, a lot of times people are ready to say, ‘Okay, annually is okay.' And eventually they may let that drop off. But it also depends on did they have a mastectomy? Did they have breast conserving surgery? And then if they had reconstruction with an implant, how often do they see the plastic surgeon? Because they need to check integrity of the implant. So those schedules are really individualized.” TS 13:24  “When you think about long-term effects, I think you need to kind of think about that survivors can have both acute and long-term chronic effects. And a lot of that depends on the specifics of the treatment they had. I think as oncology nurses, we're used to, ‘We give you this chemotherapy or this agent, and these are the side effects.'” TS 15:36  “The diet issues are huge. And I think we are slow to refer to the dietician, you know, you can get them a couple of consults and because you're saying to them, ‘This is really important. We need you to lose weight or we need you to eat more of this.' Ideally, fruits and vegetables are going to be about half of your plate. And what's the difference between a whole grain and not, less processed foods, making sure that they're getting enough protein. And then once again, really kind of making sure that they're not taking a lot of supplements and extra stuff because we don't really understand all that fully and it could be harmful.” TS 34:53  “Breast cancer is a long, long journey, and I think you should never underestimate the real difference that nurses can make. I think they can ask those tough questions. And I think ask the questions that are important to patients that patients may be reluctant to ask. I think giving patients permission to talk about those less-talked-about symptoms and acknowledge that those symptoms are real and that there are some strategies to mitigate those symptoms.” TS 42:28   

BUFFALO, NY – March 12, 2025 – A new #editorial was #published in Oncotarget, Volume 16, on March 10, 2025, titled “COMETgazing – interesting insights, lessons for clinical practice and a call for more precision using the biomarkerSCOPE.” Dr. Mangesh A. Thorat, affiliated with Queen Mary University of London, Homerton University Hospital, and King's College London, discusses new findings suggesting that some women diagnosed with early-stage breast cancer may not need immediate surgery. The editorial is based on results from the COMET trial, which studied women with low- to intermediate-grade ductal carcinoma in situ (DCIS). The findings raise questions about the necessity of surgery and highlight the importance of more precise screening methods for DCIS, ensuring that only those who truly need treatment receive it. Breast cancer screening programs are designed to detect cancer early, but this editorial reinforces the concern that some detected cancers may never become a real threat. The COMET trial compared two strategies for treating breast cancer: standard treatment, which includes surgery and possible additional therapy, versus active monitoring, where patients are closely observed without immediate intervention. The results indicate that many of the invasive cancers diagnosed in the monitoring group were likely present from the start rather than developing from DCIS over time. Dr. Thorat points out that these invasive cancers were often slightly larger, but they did not appear to be aggressive. These findings challenge the assumption that immediate treatment is necessary for all cases of DCIS. Researchers estimate that at least half of the invasive breast cancers in this study either take years to progress or may never progress at all. “The planned long-term follow-up of the trial may shed more light on the median length of lead-time and the proportion of IBCs regressing as well as DCIS progression under different lead-time assumptions.” Current methods for evaluating DCIS rely heavily on histological grading, which has limitations. Dr. Thorat emphasizes the need for more precise tools to determine which DCIS cases require treatment. His previous research suggests that biomarkers, such as multi-clonal estrogen receptor (ER) expression and tumor-infiltrating lymphocytes (TILs), may help predict which DCIS cases are truly at risk of becoming invasive. The editorial also highlights that many women prefer to avoid surgery when possible. In a related study, only 52% of patients in the standard care group followed through with it, indicating that more individuals are willing to consider alternatives to surgery. This fact underscores the importance of developing accurate biomarkers to guide treatment decisions and ensure that patients receive appropriate care without unnecessary interventions. As researchers continue to follow patients from the COMET trial, they hope to learn more about how invasive breast cancers behave over time. Finally, Dr. Thorat encourages clinicians and scientists to rethink breast cancer treatment and develop better ways to identify which patients truly need surgery—and which do not. DOI - https://doi.org/10.18632/oncotarget.28698 Correspondence to - Mangesh A. Thorat - m.thorat@qmul.ac.uk To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

There’s a new, and easier test on the way to evaluate a woman's risk of breast cancer. Karine Ippersiel is the President and CEO of the Quebec Breast Cancer Foundation. She spoke to Ken Connors about how the test works.

In this episode of Our Womanity Dr. Rachel Pope sits down with Dr. Lily Gutnik, a breast surgeon and global health advocate dedicated to advancing equitable healthcare for women.Dr. Gutnik's journey is deeply rooted in her experience as a first-generation immigrant. After her parents fled religious persecution in the former USSR, she grew up in the United States, where she developed a profound appreciation for education and hard work. Her global perspective—shaped by extensive travel, multilingual abilities, and cross-cultural training—has reinforced her commitment to diversity, equity, and inclusion in healthcare.A firm believer in innovative, cross-disciplinary collaborations, Dr. Gutnik focuses on implementing high-quality, cost-effective breast cancer care, particularly for vulnerable women. She champions a convergence science approach to address the complex root causes of health disparities, using implementation science to develop interventions that drive health equity.For Dr. Gutnik, becoming a breast surgeon is more than a profession—it is a mission to empower women through health. Tune in as she shares her insights on building sustainable healthcare solutions, tackling systemic inequities, and the future of breast cancer care.Featured in this episode: Stigma around breast cancer and mistrust in the African and African American community Discovering Hands Initiative empowering blind women Uninsured and underinsured patients still face barriers to care Advancing breast cancer treatment in the US – But at what cost? Tanzania leading the charge in education, awareness, and stigma reduction Tuskegee Syphilis StudyFollow us on social media: Instagram: @drrpope TikTok: @vulvadoctor Twitter: @drrpope LinkedInWant more from Our Womanity?If you enjoyed this episode of Our Womanity, please subscribe, rate, and leave a review. Your feedback helps us continue to bring you engaging and empowering content.

In this episode, Dr. Shawn Tassone discusses various aspects of hormone health, particularly focusing on breast cancer screening methods including mammography, ultrasound, and thermography. He shares insights from his book, 'The Hormone Balance Bible', and emphasizes the importance of understanding different testing methods, their pros and cons, and emerging technologies in breast imaging. The conversation aims to empower women with knowledge about their health and the options available for cancer detection and prevention. Episode Highlights: The Hormone Balance Bible provides insights into hormone imbalances. Mammography, ultrasound, and thermography are key breast cancer screening methods. Each screening method has its own pros and cons. Thermography is a physiological test, while mammography and ultrasound are structural tests. Mammograms can miss fast-growing tumors due to their nature. Ultrasound can detect some tumors missed by mammograms. Thermography has a lower false positive rate compared to mammograms and ultrasounds. Emerging technologies like the QT scan may offer new options for breast imaging. Prevention is more important than detection in cancer care. Women should choose the screening method that resonates with them.  

“This is what totally drives the treatment decisions, and that's why having that pathology report when the nurse is educating the patient is so important, because you can say, well, you have this kind of breast cancer, and this kind of breast cancer is generally treated this way,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in Missouri, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about what oncology nurses need to know about breast cancer treatment.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 1.0 contact hours (including 15 minutes of pharmacotherapeutic content) of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to breast cancer treatment considerations.  Episode Notes   Complete this evaluation for free NCPD. Previous ONS Podcast™ site-specific episodes: ONS Voice articles: Episode 348: Breast Cancer Diagnostic Considerations for Nurses Episode 345: Breast Cancer Screening, Detection, and Disparities ONS Voice articles: An Oncology Nurse's Guide to Cascade Testing  Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  Learn How to Read a Germline Genomic Testing Report  Learn How to Read a Somatic Biomarker Testing Report  Sexual Considerations for Patients With Cancer  ONS books: Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses  ONS courses: Breast Cancer Bundle  Breast Cancer: Treatment and Symptom Management  ONS Biomarker Database results for breast cancer ONS Next-Generation Sequencing Sample Report  ONS Learning Libraries: Breast Cancer Genomics and Precision Oncology   American Cancer Society: Breast Cancer Facts and Figures  Your Breast Pathology Report: Breast Cancer National Comprehensive Cancer Network   National Cancer Institute Breast Cancer—Patient Version  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “Local treatment is typically going to consider some kind of surgery with or without radiation, depending on the surgery and the extent of the breast cancer. All women are going to have, and today when you use the word women, individuals assigned female at birth, they are the vast majority of individuals being treated for breast cancer, but for individuals assigned male at birth, there's not near as much research, but generally their treatment is very similar. So that's something to kind of keep in the back of your mind.” TS 2:39  “This is very confusing for patients because they're like, ‘Well, my friend at church had this and why am I getting this and why are they getting something different?' And that is because of the pathology report. So taking that time to explain that with a pathology, I think is really important.” TS 8:31  “When they see the breast surgeon, all individuals are going to have some kind of axillary evaluation.  Now, hopefully it's going to be a sentinel lymph node. So they're going to, at the time of surgery, put a tracer and, you know, they're going to take out maybe one, two, three lymph nodes and hopefully, you know, there is not a lot of disease there. And if that's the case, they're kind of done with that. So the sentinel lymph node evaluation, it's really more to stage and provide that information, but it kind of sets the stage a lot of times for the other treatments selections. And I think people need to realize that this is important. This is a very important procedure.” TS 15:31  “Years ago, when women had a breast mass, they went to the OR and it was biopsied in a frozen section and if it was positive, they had a mastectomy. So women would wake up and they'd be feeling their chest because they're like, ‘What happened here?' And that is not great care. It doesn't give that woman any autonomy, but it was the best that could be done at that point. Now, with the diagnostic where we can do a needle biopsy, they can kind of stop and take a timeout and we can kind of clinically stage that.” TS 17:04  “For women that really desire breast-conserving therapy, they can anticipate that postoperatively at some point, they're going to have treatment to the entire breast, we typically call whole breast radiation, and then they may have a boost. Now, in many, many probably cases, that's going to be over five to six weeks, Monday through Friday. So the treatment itself doesn't take but a couple of minutes, but you have to get to the facility. And even though we streamline check-in processes and whatnot, you have to get undressed, you have to get positioned on the table. So it is a commitment, and it can be disruptive.” TS 24:49  “The hormone-blocking agents are going to be the cornerstone of all those treatments for anyone who has hormone receptor–positive breast cancer. So they are going to take these agents and as you said, they're probably going to take them for 5–10 years. It's quite the journey.” TS 32:33   “I think you need to be mindful that if someone has had germline testing and they've tested positive, they are not only worried about themselves, and they are worried about the rest of their family. That is a big deal. And even though I'll hear mothers say, ‘I feel so guilty, now my daughter has this,' now, I've never heard a daughter come and say, ‘Gosh, I wish my mom hadn't had me because of this.' There's a lot of feeling and emotion that goes on with that, and realize that those individuals are probably going to have fairly complicated management that goes over and above their breast cancer.” TS 41:50 

Howie and Harlan are joined by Deborah Rhodes, a Yale internist and the chief quality officer for Yale Medicine and Yale New Haven Health System. They discuss how she helped develop a better approach to scanning for breast cancer in women with dense breast tissue, and the obstacles to wide adoption. Harlan reports on the Trump administration's plan to slash indirect support for research; Howie explains the potential consequences of cuts to Medicaid. Links: Flu and Research Cuts “Weekly US Influenza Surveillance Report: Key Updates for Week 5, ending February 1, 2025” “This Is One of the Worst Flu Seasons in Decades” “Court Pause on Trump Cuts to Medical Research Funds Is Expanded Nationwide” “What National Institutes of Health funding cuts could mean for U.S. universities” Breast-Cancer Screening TED Talk by Deborah Rhodes: “A test that finds 3x more breast tumors, and why it's not available to you” Deborah Rhodes: “A Survey of Patient Experience During Molecular Breast Imaging” Mayo Clinic Breast Clinic: “How To Decide What To Do If You Have Dense Breasts On Mammogram” Deborah Rhodes: “Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts” Cleveland Clinic: Fibroglandular Density Are You Dense? “Evaluation of a Clinical Decision Support System for Imaging Requests” Medicaid “House Republicans release budget plan, with trillions in tax and spending cuts” “Trump's return puts Medicaid on the chopping block” “House GOP releases budget calling for trillions in cuts to taxes and spending” “Red states likely to feel the pain of Medicaid cuts” Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

“We know that some women are going to get called back. And it's just because usually they can't see something clearly enough. And so in most cases, those women are going to get cleared with one or two images, and they're going to say, ‘Oh, we compress that better, we checked it with an ultrasound, we're fine.' That woman can go ahead and go. But we don't want to miss those early breast cancers,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in Missouri, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about what oncology nurses need to know about breast cancer diagnosis.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 31, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to breast cancer diagnostic considerations.  Episode Notes   Complete this evaluation for free NCPD.  Previous ONS Podcast™ site-specific episodes: Episode 345: Breast Cancer Screening, Detection, and Disparities  ONS Voice articles: An Oncology Nurse's Guide to Cascade Testing  Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  ONS books: Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses  ONS courses: Breast Cancer Bundle  Breast Cancer: Prevention, Detection, and Pathophysiology  ONS Biomarker Database results for breast cancer  ONS Learning Libraries:  Breast Cancer  Genomics and Precision Oncology    American Cancer Society: Early Detection and Diagnosis  Breast Cancer Facts and Figures   Your Breast Pathology Report: Breast Cancer  National Comprehensive Cancer Network    National Cancer Institute Breast Cancer—Patient Version  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “When a woman gets a callback, that is incredibly anxiety provoking, because they're very scared and they don't know what it means. And I think that's a place where oncology nurses can remind—if it's patients or friends who are asking—that just because you have a call back, doesn't mean you have a malignancy.” TS 8:16  “We also know that when we call somebody back, that's very scary and anxiety provoking. And we don't want to subject women to unnecessary anxiety and stress through the procedure. And if it's too stressful, they won't come back again. That is actually a big harm that we don't want to occur. That's considered an acceptable amount. So we know that some women are going to get called back, and it's just because usually they can't see something clearly enough.” TS 11:26  “I think one of the most important things is to really help that woman understand the biopsy report. So now everybody, with most of the electronic medical records, that woman seeing that biopsy result—maybe before her provider is seeing it, depending on whether they get a chance to call that individual. But, you know, they could get a notification in their medical record, or a new report is available, and they can click on there and they could be looking at something that is very scary, not necessarily a good time, you know, like they're getting ready to do something. And so that is a problem overall with sometimes getting bad news in oncology.” TS 15:09  “Sometimes it's really good [for patients to bring] someone who can just be that set of ears or who can answer those questions, who's emotionally involved but maybe not so emotionally involved, if that makes sense. And I think that that is something we can really encourage people to identify that person who's going to really be able to support them.” TS 16:42  “When we approach a pathology report, the patient, you know, if they open that on their own, they're just going to see breast carcinoma, or they aren't going to look at all of the details of it. They can be quite overwhelming to look at. But I think that it's important to kind of take the patient through it, step by step, and realize that it's often a case of repeated measures—that you might do it and then you might do it again the next day or a day later.” TS 20:55  “Breast cancer care has changed so much over the past few decades. And I think people forget, you know, I've been in the business a long time, but years ago, everybody kind of got the same treatment if they got diagnosed. And we now understand so much about breast cancer treatment, but I think that has come on the shoulders of so, so, so many women who have enrolled in clinical trials to help us understand pathology better, to help us understand the impact of certain treatments. And so I think, first of all, we need to thank those women who have generously contributed to this base of knowledge. And it's a place where those clinical trials have really made a difference.” TS 35:46

Watch hol+ by Dr. Taz MD on YouTube: https://www.youtube.com/@DrTazMD/podcastsThe incidence of breast cancer is rising and has now surpassed lung cancer as the leading cancer worldwide. This script features a comprehensive discussion between the host and Dr. Kristi Funk, a double board-certified breast cancer surgeon and lifestyle medicine doctor. The conversation covers the rising rates of breast cancer, key risk factors such as diet, exercise, and lifestyle choices, and the role of early detection and screening. Dr. Funk shares her personal experiences, insights on how younger and older women can reduce their risk, the impact of hormone replacement therapy, and the importance of lifestyle modifications. Additionally, advancements in breast cancer treatments, including immunotherapy and personalized medicine, are explored as hopeful developments in the fight against breast cancer.About Dr. Kristi FunkKristi Funk, M.D. is a double board-certified breast cancer surgeon, and lifestyle medicine doctor, bestselling author, and international speaker. She graduated from Stanford University in 1991, received her medical degree from UC Davis, completed her surgical residency in Seattle, and a breast cancer fellowship at Cedars-Sinai in Los Angeles. She excelled as a Director of the Cedars-Sinai Breast Center until 2009 when Dr. Funk co-founded the the Pink Lotus Breast Center in Los Angeles where she currently practices. She has helped thousands of women navigate breast issues, including celebrities like Angelina Jolie and Sheryl Crow. Dr. Funk's nutritional science expertise sparked twin passions: the online women's social network, Pink Lotus Power Up, and her annual in-person or virtual Cancer-Kicking! Summits. She is the go-to breast expert for Good Morning America and Dr. Phil's Merit Street Media; she was a co-host of The Doctors tv show, and has repeatedly appeared on Today, Rachael Ray, The Dr. Oz Show, CNN, The View, and more. She resides in Los Angeles, CA, with her husband and triplet sons.Thank you to our sponsorBiOptimizers:  bioptimizers.com/holplus04:36 Current Trends and Statistics in Breast Cancer08:10 The Role of Genetics and Lifestyle in Breast Cancer11:16 Diet, Exercise, and Environmental Factors36:49 The Impact of Emotional Health on Breast Cancer43:05 Breast Cancer Screening for Young Women49:30 The Debate on Mammograms and Ultrasounds52:22 Understanding DCIS: Overdiagnosis and Overtreatment1:00:24 Hormone Replacement Therapy and Breast Cancer01:15:24 Future of Breast Cancer Care and TreatmentStay ConnectedSubscribe to the audio podcast: https://holplus.transistor.fm/subscribeSubscribe to the video podcast: https://www.youtube.com/@DrTazMD/podcastsFollow Dr. Taz on Instagram: https://www.instagram.com/drtazmd/https://www.instagram.com/liveholplus/Join the conversation on X: https://x.com/@drtazmdTikTok: https://www.tiktok.com/@drtazmdFacebook: https://www.facebook.com/drtazmd/Connect with Dr. Kristi Funk:https://www.instagram.com/drkristifunkhttps://pinklotus.com/Host & Production TeamHost: Dr. Taz; Produced by Rainbow Creative (Executive Producer: Matthew Jones; Lead Producer: Lauren Feighan; Editors: Jeremiah Schultz and Patrick Edwards)Don't forget to like, subscribe, and hit the notification bell to stay updated on future episodes of hol+

Full article: Access to Breast Cancer Screening: Disparities and Determinants—AJR Expert Panel Narrative Review In this AJR Conversation, Breast Imaging Section Editor Wei Yang, MD speaks with Anand Narayan, MD, PhD, FSBI, about his team's recently published article analyzing persistent inequities in screening, focusing on race, ethnicity, socioeconomic status, disabilities, health insurance, and geography.

“The statistic you always kind of want to keep in the back of your brain is that over a lifetime, one in eight women will be diagnosed with breast cancer. So that means for an individual assigned female at birth, there's a 13% chance that if that individual lives to age 85, that they will be diagnosed with breast cancer. So, it's the most common cancer diagnosed in this group,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in St. Louis, MO, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about breast cancer screening.  Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by January 10, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to breast cancer screening, detection, and disparities.  Episode Notes   Complete this evaluation for free NCPD. ONS Podcast™ episodes:  Episode 333: Pharmacology 101: CDK Inhibitors  Episode 316: Pharmacology 101: Estrogen-Targeting Therapies  ONS Voice articles:  An Oncology Nurse's Guide to Cascade Testing  Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  Encourage Breast Cancer Screening in Childhood Cancer Survivors   Genetic Disorder Reference Sheet: BARD1  Genetic Disorder Reference Sheet: BRCA1 and BRCA2 Hereditary Cancers  Genetic Disorder Reference Sheet: PALB2  ONS books: Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses Clinical Journal of Oncology Nursing article: Germline Cancer Genetic Counseling: Clinical Care for Transgender and Nonbinary Individuals  ONS courses:   Breast Cancer Bundle  Breast Cancer: Prevention, Detection, and Pathophysiology  ONS Learning Library: Genomics and Precision Oncology   American Cancer Society Breast Cancer Facts and Figures  Breast Cancer Risk Assessment Calculator  Breast Cancer Risk Assessment Tool   National Comprehensive Cancer Network   Tyrer-Cuzick Risk Assessment Calculator  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “Unfortunately, probably about 42,500 women die every year from breast cancer, and that number still seems really high because mammography screening has really enabled us to detect breast cancer in many, many cases when it would be most treatable. And so that's a place where you would like to see some real progress.” TS 3:32  “Primary prevention for all individuals, which is always best to prevent, would include 150 minutes of intentional exercise, watching the diet, keeping that weight as low as possible—we want more muscle and less fat mass—and limiting alcohol intake. Then we go and we talk about screening.” TS 7:29  “The most recent statistic, and this kind of is post-COVID, is that 67% of women age 40 and over have had breast cancer screening in the last two years, which means that there's a hunk of women, 33% of women who have not had breast cancer screening in the last two years and that who are 40 and over. And that to me is a really, really sad statistic because that's a missed opportunity for screening.” TS 11:32  “Sometimes we forget that women and individuals who've had breast cancer, especially if they had it at a younger age, their risk of a second breast cancer over time is about 1% or 2% per year. So, if you have a first breast cancer at 40, and you live another 30 years, two times 30 is 60, that risk is substantial. A lot of times we don't see as much anymore, which is good. Individuals who had a lot of radiation to the chest, we used to see a lot of young individuals having radiation therapy for Hodgkin's disease that encompassed the chest, and a lot of them were diagnosed with breast cancer afterwards.” TS 15:31  “One of the things that always makes me really sad is that probably less than 40% of people who are eligible for this cascade testing, and mind you, many of the laboratories, if we test a parent and say they have a pathogenic variant, they will offer free testing to relatives for 90–120 days in that lab. They don't even have to pay for the genetic test. They just have to get the counseling and send it. But less than 40% of individuals who would benefit from cascade testing ever get it done.” TS 35:02  “I have had this privilege of sitting for decades watching genetics. That's the only area I've ever worked in that is always completely changing. And just when you think you got it, there is something new and it's really driving our oncology care. And I would really encourage people, I know we've said it about 10 times now, to look at that Genomics and Precision Medicine Learning Library, there are resources in there if you want to spend 3 minutes, 5 minutes, 10 minutes—if you got a whole hour or two, there's courses. There are so many things in there, and if you really want to become more savvy, you can, and that's a great place to start.” TS 45:34

Beat Cancer hosts Chris Joyce and Stephanie Winn speak with Dr. Diana Miglioretti and Dr. Laura Fejerman about the importance of breast cancer screening and how our new mobile mammography unit will make screenings more accessible to women in Northern California. To learn more about the UC Davis Comprehensive Cancer Center, visit https://health.ucdavis.edu/cancer/

Full article: Automated Breast Ultrasound With Remote Reading for Primary Breast Cancer Screening: A Prospective Study Involving 46 Community Health Centers in China Antonino Andrea Blandino, MD, discusses the AJR article by Dang et al. evaluating the use of automated breast ultrasound with remote reading for breast cancer screening.

The nervous energy is palpable across the United States, as Kamala Harris and Donald Trump wait for the verdict of the voters. We have coverage from both U.S. presidential campaigns, and on the races for the House and Senate.  And: Canada is a target for Russian sabotage - including a dangerous plot to plant explosive devices on planes bound for North America. Ottawa is warning Moscow it won't tolerate any threat to Canadians. Plus: Canada doesn't collect cancer data by race or ethnicity - but that could be crucial to know who needs early screening for breast cancer. And more  

Dr. Aurela Clark, a radiologist with the Comprehensive Breast Care Center at UK Markey Cancer Center, discusses the impact of new breast cancer screening guidelines from the FDA.

Are you worried about breast cancer screenings?  On today's episode, Dr. Diane talks with Dr. Yvonne Carney, an integrative gynecologist. Dr. Yvonne shares a new way to screen for breast cancer called QT Imaging. It's safer and more comfortable than regular mammograms.  There's no radiation, no pain, and it's great for women with dense breasts. Dr. Yvonne also talks about anxiety, hormones, and why knowing your options matters.  Don't miss this chat if you want better choices for your breast health.   About the Guest: Dr. Yvonne Karney is a gynecologist with over 25 years of experience dedicated to women's health. She now leads an integrative practice in the Chicago suburbs, where she's transforming breast imaging with a cutting-edge option that matches MRI quality—without radiation, IV contrast, or painful compression. Dr. Karney is on a mission to expand breast screening options and educate women about the risks and benefits of current breast cancer screening methods. Explore QT Imaging and book your scan today!:https://vitalityrenewal.org/breast-imaging/??  Website: https://vitalityrenewal.org/breast-imaging/??  – Our advocacy is centered around providing a supportive space for women to reclaim sexual vitality and joy for good. Help us achieve this by subscribing to our podcast and sharing us with your friends and family.

October is breast cancer awareness month. Here's what you need to know about detection and screening.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Although breast cancer deaths have dropped by about 40% since 1989, breast cancer diagnoses in younger women are increasing. We'll help you understand your personal risk, when and how often you should get mammograms, and how to advocate for yourself in the health care system.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

About My Guest: Dr. Jenn Simmons is a breast cancer surgeon turned Integrative oncologist on a mission to change how we diagnose, treat, and screen for breast cancer. Her best selling book, the smart woman's guide to breast cancer, is changing the narrative around breast cancer and will undoubtedly change the lives of millions of women worried about or affected by a breast cancer diagnosis. She is opening the first perfection imaging center, which accurately screens for breast cancer using revolutionary new technology without pain, compression, or radiation. No more mammograms ladies ! Social Handles: Website Facebook YouTube Dr Simmons' Podcast Summary: In this episode of Back to the Basics, Dr. Cassie Smith hosts Dr. Jenn Simmons, a former breast cancer surgeon turned integrative oncologist, to discuss the shortcomings of traditional breast cancer screening and the potential of safe, alternative therapies. Dr. Simmons sheds light on how mammograms may not save lives as commonly believed, often leading to overdiagnosis and unnecessary treatments that compromise patients' quality of life. She shares insights from studies and patient cases, explaining how breast cancer growth is unpredictable and why current screening methods fail to identify which cancers need intervention. The conversation highlights Dr. Simmons' advocacy for more effective and less invasive breast cancer screening methods, such as QT scanning, which provides better results without the pain and radiation associated with mammograms. They also explore the life-changing benefits of bioidentical hormone therapy for breast cancer survivors, debunking the myth that hormone replacement fuels cancer recurrence. Dr. Simmons emphasizes the importance of personalized, holistic care to help survivors regain their vitality, reduce post-treatment complications, and improve their long-term health outcomes. Timestamps: 01:12 - Guest Introduction: Dr. Jenn Simmons 02:50 - The Problem with Traditional Breast Cancer Screening 05:00 - Overdiagnosis and Its Emotional Impact 07:45 - Alternative Breast Cancer Screening 10:12 - Bioidentical Hormone Therapy After Breast Cancer 14:20 - Addressing Post-Treatment Symptoms 18:50 - Holistic Oncology: Personalized Care 25:15 - Hormone Therapy Myths 40:00 - Future of Breast Cancer Care 55:00 - Bioidentical Hormones in Cancer Recovery 1:10:00 - Wrapping Up: Empowering Women 1:15:00 - Closing Remarks Connect with Modern Endocrine: Check out the ⁠website⁠ Follow Cassie on ⁠Instagram⁠ Follow Cassie on ⁠Facebook⁠ Follow Cassie on ⁠YouTube⁠ Follow Cassie on ⁠TikTok⁠ Sign up for Modern Endocrine's ⁠newsletter⁠ ⁠Disclaimer ⁠

John Hogan, the Minister of Health and Community Services of Newfoundland and Labrador responds to concerns regarding the lack of action to reduce the age for breast cancer screening.

On Tuesday, we heard from the advocacy group Dense Breasts Canada, as well as NAPE. They expressed their concerns about the province's delay in moving on a reduction in the recommended age for breast cancer screenings from 50 to 40. Premier Andrew Furey said the province was taking 'immediate action,' but NL Health Services said it needed time to ensure resources were in place. Five months later, this change has still not been started. Last week, CBC's Alex Kennedy spoke with John Hogan, the Minister of Health and Community Services of Newfoundland and Labrador.

“I see myself as an educator first and foremost,” said Bridget Oppong, MD, an OSUCCC-James surgical oncologist who specializes in breast cancer surgery at the Stefanie Spielman Comprehensive Breast Center and is also the deputy director of the James Center for Cancer Health Equity. In this episode, Oppong shares her wealth of knowledge about the importance of self-examinations and breast cancer screenings; advances in surgery, chemotherapy and immunotherapy; radiation; and outreach programs to underserved communities in Columbus and throughout Ohio. “Early detection is saving lives,” she said. “The five-year survival rate for early-stage breast cancer is over 90 percent … [and for women diagnosed with later-stage breast cancer that has metastasized] we can manage their breast cancer and they can still live a long life.” Self-examinations and annual mammogram screenings are the key to early detection. “I always advocate for self-examinations,” said Oppong, who described how often and what to look for during a self exam. “And if you notice anything different, bring it to medical attention immediately, to your primary-care physician or oncologist.” The recommended age for women to begin annual mammograms is 40. “But if you have a family history of breast cancers or any cancers at an early age, I recommend starting mammograms five to 10 years earlier,” Oppong said. “For example, if your sister was diagnosed with breast cancer at 35, I want you to get started at 30 at the latest.” The average age for diagnosis of breast cancer is about 60, but Oppong said more younger women are being diagnosed in recent years. She also explained the significance of the BRCA1 and BRCA2 (the breast cancer inherited mutations) and how having this mutation increases the breast-cancer risk and means starting mammograms earlier and adding MRIs for some patients. She also described how breast feeding can reduce a women's risk of developing breast cancer. As for treatment, “we have seen awesome advances in all three modalities: surgery, medical (such as chemotherapy and immunotherapy) and radiation,” Oppong said. She described some of the advances in surgery, including the nipple-sparing surgery she performs and how she works with plastic surgeons. Oppong is passionate about and determined to reach out to underserved communities. “The advancements are real and are amazing and our focus is to make sure that all women and men have equitable access to all levels of cancer care from screenings all the way through to survivorship.”

Welcome back to the Stronger Bones Lifestyle Podcast. In Episode 83, our host Debi Robinson welcomes back Dr. Yvonne Karney to discuss informed consent when it comes to traditional mammogram screenings and introduces us to a groundbreaking alternative technology, QT Imaging.***********************To learn more and join the Stronger Bones Lifestyle Community click the link below:https://debirobinson.com/the-stronger-bones-lifestyle-community/Membership is free for 30 days and you will not be asked to enter a credit card. I look forward to meeting you there!!!***********************Dr. Yvonne Karney, with over 25 years of experience in gynecology, delves into the benefits, limitations and risks of mammogram screenings. Dr. Yvonne underscores the importance of patient awareness, advocating for informed choices without judgment, allowing women to make empowered healthcare decisions.Join Debi and Dr. Yvonne as they delve into QT Imaging, a new breast screening modality, utilizing both traditional and transmission ultrasound. QT Imaging offers a more comfortable and potentially more accurate option for women, especially those with dense breasts or implants. Dr. Yvonne shares her efforts to bring affordable and superior breast screening technologies to the forefront, empowering women to take charge of their healthcare.Tune in to hear Debi and Dr. Yvonne share a hopeful future of improved breast health and overall wellness stemming from women being able to make educated choices. Key  Takeaways:[4:04] Breast health5:04] Informed consent[8:14] The benefits of breast cancer screening[9:30] The limitations to mammography[14:19] Three types of breast tissue and dense breasts[18:39] The potential risks of mammography[25:09] Alternatives – QT imaging[33:23] Thermography[39:05] Power and choice[43:42] Estimated price for the scan[44:58] Breast implants and explantsWhere to Find Guest:WebsiteQlarity Breast ImagingChicago Breast ImagingQT Imaging WebsiteInstagramYouTubeEpisode 78: Dr. Yvonne Karney MD: Functional Gynecologist & Hormone LocksmithJoin the Stronger Bones Lifestyle Community for Free:https://debirobinson.com/the-stronger-bones-lifestyle-community/Memorable Quotes:"The vast majority of people who have bone health issues are in that breast cancer awareness age range." [4:26] - Dr. Yvonne"What actually does it do? what do we know what do we not know and what are the risks?" [33:08] - Dr. Yvonne"Empower. Honor the women's right to make a decision. She's smart enough to know her body, what her desires are, what her priorities are and lets talk about risks, benefits and alternatives." [39:12] - Dr. Yvonne"Yeah. It's the conversation of informed consent which you brought up, which raises questions. And then from those questions becomes the information. From the information, then the decision is in the hands of the woman to make." [39:39] - Dr. Yvonne

We are continuing our 2024 updates, this week's episode will be an intro to breast cancer. Today's will include high yield tips on screening, prevention, ductal carcinoma in situ DCIS, lobular carcinoma in situ LCIS, as well as introduce invasive localized disease.

Tracey Caton's routine mammogram likely saved her life. But it led to tough decisions to keep cancer from coming back. See how she charted a path to survivorship.

In this week's episode, we kickstart Breast Cancer Awareness month with an insightful conversation on Technology in Breast Cancer Screening, featuring Dr. Muneesh Sharma, Dr. Rajesh Pahwa and Monisha Rolle from our Imaging department. The team shares the various technologies available for screenings as well as steps taken to ensure patients have a WOW experience. Listen, subscribe and share! Need to schedule an imaging service? Book your appointment today at doctorshosp.com/register-online #breastcancerawareness #october #doctorshospitalpodcast

In the first hour of "Connections with Evan Dawson" on Tuesday, October 1, 2024, we speak with a local doctor about the new guidelines for breast cancer screening, hear a local survivor's breast cancer story and explore what community resources are available to patients dealing with the disease.

New Technologies for Breast Cancer Screening: Are they Effective? with guest Ilana Richman Sunday, September 22 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

When we launched the podcast, our employees told Dorothy, “You have to interview Brittany.”  The interview has finally arrived. Brittany Weston began as a student and is now one of The Rose's lead mammographers. During school, both her mother and grandmother were diagnosed with breast cancer. So this isn't just a career, it's a purpose. During this episode, Dorothy and Brittany discuss ultrasounds and mammograms, and how a woman's demeanor can impact the way her image appears. They also discuss how Brittany keeps calm when she finds something.See omnystudio.com/listener for privacy information.

“There is no survival advantage to screening with mammograms.” - Dr. Jenn SimmonsFor over 50 years, healthcare providers have told women how important it is to have a mammogram every year after a certain age. With mammograms positioned as the primary screening tool for breast cancer, these annual visits are dutifully maintained for years in the hope that they will act as an early warning system. Unfortunately, the data doesn't support this theory.Research shows that there was no survival advantage to screening with mammograms, nor does it result in more breasts saved. In addition, repeated radiation exposure causes thousands of breast cancers every year, as well as thousands of women treated for breast cancer that never needed to be treated. Luckily, we now have alternatives that are safer and less aggressive.Today, I'm excited to chat with Dr. Jenn Simmons, who is on a mission to change the impact of breast cancer. Dr. Jenn started her professional career as Philadelphia's first fellowship-trained breast surgeon and spent 17 years as Philadelphia's top breast surgeon. Her own illness led to her discovery of functional medicine, and she became enamored with the concept of creating health rather than killing disease. She left traditional medicine in 2019 and founded Real Health MD to help women along their breast cancer journey truly heal.In this conversation, Dr. Jenn and I discuss her personal experiences with breast cancer, the complexities of its detection and treatment, the root causes of breast cancer, how environmental toxins and lifestyle factors affect cancer development, innovative imaging technology for safer breast cancer screening, why you shouldn't be afraid of estrogen, and more. Enjoy the episode!To learn more, visit the show notes at https://savemythyroid.com/podcast/alternative-breast-cancer-screening-and-treatment-options-with-dr-jenn-simmons-155/. Do You Want Help Saving Your Thyroid? Access hundreds of free articles at www.NaturalEndocrineSolutions.com Visit Dr. Eric's YouTube channel at www.youtube.com/c/NaturalThyroidDoctor/ To work with Dr. Eric, visit https://savemythyroid.com/work-with-dr-eric/

Joining us on Well Said is Dr. Nina Vincoff, Division Chief of Breast Imaging at Northwell Health, and Medical Director and Vice President for Clinical Initiatives and Patient Experience for the Katz Institute for Women's Health to talk about all aspects of breast cancer screening. Including new technology, new guidelines about how to use that technology and new insights about women's health that are coming through the application of artificial intelligence.

Episode Highlights With Dr. Jenn SimmonsThe downfall of imaging as breast cancer prevention is that this is really just early diagnosis and not preventionFar beyond cancer, there are a lot of benign changes in the breast that can cause stress for peopleWhy screening doesn't improve outcomes as much as we once thoughtNo matter how many women we screen per year, the exact same number die of breast cancer and present with aggressive diseaseStatistically, mammograms don't save lives or breasts and just have increased the risk of mastectomy How mammography may actually contribute to breast cancerMammography - if you screen 2,000 women, you can potentially save one woman but cause 10 who didn't need it to be treated for breast cancerThe new type of imaging that is radiation-free and lower risk with better resolution and results How absurd it is that we are using a method that causes cancer to screen for cancerResources We MentionThe Smart Woman's Guide to Breast Cancer by Dr. Jenn SimmonsReal Health MD - websitePerfeQTion Imaging - imaging centers

In this episode of The Curbsiders Podcast, the team delves into the recently updated breast cancer screening recommendations from the U.S. Preventive Services Task Force (USPSTF) with Dr. Wanda Nicholson (@wnicholsonobgyn), an expert in preventive medicine, diversity, equity and inclusion, and women's health and the Chair of the Task Force.  Join us as we review the newest screening mammography recommendations, evidence for earlier screening for all women, the challenge of dense breast findings, and more. Importantly, we discuss disparities in breast cancer outcomes and the need to better understand and address them. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro and Guest Background Case Updated Breast Cancer Screening Recommendations Rationale for screening age Considerations for findings of dense breasts Balancing benefits and harms Racial disparities Research Gaps Outro Credits Producer, writer, show notes, infographic, and cover art: Fatima Syed MD Hosts: Paul Williams MD, FACP and Fatima Syed MD    Reviewer: Emi Okamoto MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Wanda Nicholson MD, MBA, MPH

In this enlightening episode of Risky Benefits, we dive deep into the future of breast cancer screening. With less than 40% of women getting annual mammograms due to various fears and inconveniences, screening innovation couldn't be more timely! Listen as special guest Dr. Monique Gary, a renowned breast surgeon and Chief Medical Officer at Bexa brings us up to speed on Bexa's revolutionary elastography technology, designed to provide a painless, radiation-free alternative to traditional mammograms. This podcast episode explores the critical importance of early detection in breast cancer, how it drastically improves survival rates, and Bexa's mission to make these life-saving exams accessible to all women, including those in underserved communities. Plus, find out how employers are partnering with Bexa to offer their employees convenient and comprehensive breast cancer screenings, giving women peace of mind and control over their health.Get ready for an episode filled with hope, innovation, and crucial information on groundbreaking technology and a compassionate, women-led approach.To listen in and subscribe to more episodes, visit our website: fbmc.com/podcast.

For this episode, Cara and Missi take a little detour into personal territory while also reviewing new breast cancer screening guidelines from the United States Preventive Services Task Force. They discuss the emotional toll of abnormal screening results and share insight into patient-centered, holistic care of patients undergoing screening tests for cancer.  #WhenNormalIsNotNormal #BreastCancerScreening #MammogramsSaveLives #USPSTF #Cancer @americancancersociety @acog_org 

There continues to be great confusion regarding the impact of hormone therapy on the breast. And despite the known benefits of hormone therapy, and reassuring data regarding the impact of hormone therapy on breast cancer, most clinicians are still reluctant to prescribe it, and most women are reluctant to take it. Even more so if a woman is high risk for breast cancer or has a breast cancer diagnosis.  In this episode, I am joined by Dr. Corinne Menn, a board-certified Ob GYN and menopause expert who herself had a breast cancer diagnosis when she was in her 20s. We will be reviewing the latest research on the impact of estrogen on the breast in several different scenarios.  PREGNANCY post breast cancer Women who have a BREAST CANCER diagnosis  Women with a FAMILY HISTORY of breast cancer Women with a BRCA MUTATION after prophylactic ovary removal The approach to therapy for women with a NEW BREAST CANCER DIAGNOSIS The use of local vaginal estrogen in women with a breast cancer diagnosis that are taking TAMOXIFEN or using an AROMOTASE INHIBITOR If a LOCAL VAGINAL ESTROGEN needs to  be used at the lowest dose What to do if your DOCTOR NOT WILLING to prescribe local or systemic estrogen (list of articles to share is below)  If a woman with a breast cancer diagnosis can use TESTOSTERONE for libido and other possible benefits Dr. Corrine Menn https://drmenn.com/ @drmennobgyn For more information: Episode 124 All Hormones Are Not Created Equal with Dr. James Simon Episode 65- The Dilemma of Menopause and Breast Cancer Episode 31 The TRUTH About Hormone Therapy: Does it CAUSE or Does it PREVENT Breast Cancer? Episode 28: The BEST approach for BREAST Cancer Screening and Risk Reduction with Dr. Lisa Larkin Dr. Streicher's Inside Information podcast is not intended to replace medical advice and should be used to supplement, not replace, care by your personal health care clinician. Dr. Streicher disclaims liability for any medical outcomes that may occur because of applying methods suggested or discussed in this podcast. Scientific Articles  Hormone Therapy and Risk of Breast Cancer Bluming AZ, Hodis HN, Langer RD. 'Tis but a scratch: a critical review of the Women's Health Initiative evidence associating menopausal hormone therapy with the risk of breast cancer. Menopause. 2023 Dec 1;30(12):1241-1245.  Bluming AZ. Introduction: Estrogen Reconsidered: Exploring the Evidence for Estrogen's Benefits and Risks. Cancer J. 2022 May-Jun 01;28(3):157-162.  Hodis HN, Sarrel PM. Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? Climacteric 2018;21:521–8. Levy B, Simon JA. A Contemporary View of Menopausal Hormone Therapy. Obstet Gynecol. 2024 Mar 14.  Chlebowski RT, Aragaki AK, Pan K, Mortimer JE, Johnson KC, Wactawski-Wende J, LeBoff MS, Lavasani S, Lane D, Nelson RA, Manson JE. Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis. Breast Cancer Res Treat. 2024 Apr 23. doi: 10.1007/s10549-024-07307-9.  Pan K, Lavasani S, Aragaki AK, Chlebowski RT. Estrogen therapy and breast cancer in randomized clinical trials: a narrative review. Menopause. 2022 Sep 1;29(9):1086-1092.  Use of Hormone Therapy in Women with a Breast Cancer Diagnosis Bluming A. Hormone replacement therapy after breast cancer: it is time. Cancer J 2022;28:183–90.  Bluming AZ. Safety of systemic hormone replacement therapy in breast cancer survivors. Breast Cancer Res Treat. 2022 Feb;191(3):685-686. doi: 10.1007/s10549-021-06479-y.  Fahlén M, Fornander T, Johansson H, Johansson U, Rutqvist LE, Wilking N, von Schoultz E. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer. 2013 Jan;49(1):52-9. Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, et al. Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study. Menopause 2016;23:1199–203 Hormone Therapy in Women with BRCA Mutation Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers. JAMA Oncol. 2018 Aug 1;4(8):1059-1065.. Lauren Streicher, MD is a clinical professor of obstetrics and gynecology at Northwestern University's Feinberg School of Medicine, and the founding medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society.  Sign up to receive DR. STREICHER'S FREE NEWSLETTER Dr. Streicher is the medical correspondent for Chicago's top-rated news program, the WGN Morning News, and has been seen on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBCNightlyNews,20/20, and World News Tonight. She is an expert source for many magazines and serves on the medical advisory board of The Kinsey Institute, Self Magazine, and Prevention Magazine. She writes a regular column for The Ethel by AARP and Prevention Magazine.  Subscribe and Follow Dr. Streicher on  DrStreicher.com Instagram @DrStreich Facebook  @DrStreicher YouTube  DrStreicherTV Books by Lauren Streicher, MD  Slip Sliding Away: Turning Back the Clock on Your Vagina-A gynecologist's guide to eliminating post-menopause dryness and pain Hot Flash Hell: A Gynecologist's Guide to Turning Down the Heat Sex Rx- Hormones, Health, and Your Best Sex Ever The Essential Guide to Hysterectomy

Editor's Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 11, 2024, issue.

The announcement on breast screening goes against all of our beliefs. The Health Minister says decision not to lower Canadian breast cancer screening age prompts review. Host Alex Pierson speaks with Dr. Jean Seely, Professor of Medicine in the Department of Radiology at the University of Ottawa, Head of the Breast Imaging Section at the Ottawa Hospital. Learn more about your ad choices. Visit megaphone.fm/adchoices

The U.S. Preventive Services Task Force has updated its recommendations for breast cancer screening once again. The recommendations now stipulate that women and people assigned female at birth should begin getting mammograms at age 40, and continue every other year until age 74. The previous guidelines recommended beginning screening at age 50. These guidelines carry a lot of weight because they determine if mammography will be considered preventive care by health insurance and therefore covered at no cost to the patient.Why have the guidelines changed? And how are these decisions made in the first place? To answer those questions and more Ira Flatow talks with Dr. Janie Lee, director of breast imaging at the Fred Hutchinson Cancer Center and professor of radiology at the University of Washington School of Medicine.Transcript for this segment will be available the week after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

When should women begin receiving biennial screening for breast cancer? Find out about this and more in today's PeerDirect Medical News Podcast.

We're back!

NBC Medical Contributor Dr. Natalie Azar breaks down the new guidance provided by the “U.S. Preventative Services Task Force” on breast cancer screening. Also, NBC's Vicky Nguyen shares some big sales and deals to take advantage of in the month of May. Plus, in honor of the first day of Military Appreciation Month, some remarkable Vietnam veterans join the show to share their story. Also, Melissa Joan Hart live in studio 1a to catch up and discuss her new Lifetime movie “The Bad Guardian.”   

Interview with Wanda K. Nicholson, MD, MPH, MBA, USPSTF Chair and coauthor of Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Collaborative Modeling to Compare Different Breast Cancer Screening Strategies Screening for Breast Cancer Screening for Breast Cancer Screening for Breast Cancer Toward More Equitable Breast Cancer Outcomes